Outreach Coordinator for National Breast Cancer Prevention Trial Focuses on Minority Recruitment
PHILADELPHIA (June 28, 1999) -- Tammi Britt of West Philadelphia, has been named Community Outreach Coordinator to assist Fox Chase Cancer Center and other Philadelphia hospitals to recruit minorities for STAR (study of tamoxifen and raloxifene), the nation's second breast cancer prevention trial. As an outreach coordinator, Britt will make contact with churches, sororities, professional groups and others to acquaint members with the purposes of the study.
STAR will include 22,000 postmenopausal women at increased risk of breast cancer. The study will determine whether the osteoporosis prevention drug raloxifene (Evista) is as effective in reducing the chance of developing breast cancer as tamoxifen (Nolvadex) has proven to be.
STAR is a study of the National Surgical Adjuvant Breast and Bowel Project (NSABP), a network of research professionals, and is supported by the National Cancer Institute (NCI). Recruitment for the study is currently underway.
Britt, whose position is funded through the NSABP, is available to discuss STAR with prospective participants, encourage them to seek additional information and help them locate an institution involved in the study. She will also handle some of the concerns about clinical trials that might be present within the minority community.
"I look forward to informing people about this promising study," says Britt. "I am aware of some of the presumptions about clinical trials. It would be a shame if women missed out on this potentially life-saving study because they were misinformed."
Britt has lived in the Philadelphia area since 1988. She graduated from West Chester University with a B.S. in public health. She comes to Fox Chase after working in the area of maternal child health at a major insurance company. She also has experience in welfare-to-work programs.
For more information about STAR or if you are interested in setting up a group informational session in your neighborhood, call Fox Chase Cancer Center at 1-888-FOX CHASE.
Fox Chase Cancer Center is one of 35 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research; prevention, detection and treatment of cancer; and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.